Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06603857 · ClinicalTrials.gov registry record · Phase 2
Skin Care Regimen for Improving Photoaging Signs on the Face
A Phase 2 study, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- Not yet
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT06603857 is a Phase 2 study that has not yet begun recruiting, run by Goldman, Butterwick, Fitzpatrick and Groff. The registered enrollment target is 40 participants.
The verdict
NCT06603857, a Phase 2 study, has not yet begun recruiting, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
Compare the effectiveness of laser treatment using CE Ferulic versus vehicle pre/post laser.
Interventions
- DRUG Sham Comparator
- DRUG CE Ferulic
- DEVICE 1927nm (Clear and Brilliant Perméa®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-27 |
| Est. Completion | 2025-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06603857
The ClinicalTrials.gov registry entry for NCT06603857 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham Comparator is the first listed.
NCT06603857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06603857 about?
NCT06603857 is a clinical study titled "Skin Care Regimen for Improving Photoaging Signs on the Face". Compare the effectiveness of laser treatment using CE Ferulic versus vehicle pre/post laser.
What is the current status of trial NCT06603857?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2024-09-27. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT06603857?
The interventions under investigation include: Sham Comparator (DRUG), CE Ferulic (DRUG), 1927nm (Clear and Brilliant Perméa®) (DEVICE).
Who is sponsoring clinical trial NCT06603857?
This trial is sponsored by Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.